Recurrent Gastric Adenocarcinoma with Unusual Metastatic Localization and Excellent Responseto Docetaxel and 5-FU Continuous Infusion

Publisher： Karger

E-ISSN： 2296-5262|26|1|63-65

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.1, 2003-03, pp. : 63-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Docetaxel and Capecitabine in Patients with Metastatic or Recurrent Gastric Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 190-195

Karger

Access to resources Recommend Favorite

5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 696-700

Karger

Access to resources Recommend Favorite

Phase II Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 88-95

Karger

Access to resources Recommend Favorite

Combination of Trastuzumab and Triple FLOT Chemotherapy (5-Fluorouracil/Leucovorin, Oxaliplatin, and Docetaxel) in Patients with HER2-Positive Metastatic Gastric Cancer: Report of 3 Cases

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 505-508

Karger

Access to resources Recommend Favorite

Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report

By  

Case Reports in Oncology, Vol. 8, Iss. 2, 2015-08 ,pp. : 339-344

Karger

Access to resources Recommend Favorite